Calidi Biotherapeutics In... (CLDI)
NYSE American: CLDI
· リアルタイム株価 · USD
1.59
+0.05 (3.25%)
終値時点: Aug 14, 2026, 3:59 PM
1.60
+0.63%
時間外: 7:55 PM
Calidi Biotherapeutics Inc. (CLDI) Stock Price, Analysis & Data
3.25% (1D)
CLDIについて
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-40...
セクター Healthcare
IPO日 Nov 1, 2021
従業員数 29
上場取引所 NYSE American
ティッカー CLDI
ウェブサイト https://www.calidibio.com
決算サプライズ
Calidi BiotherapeuticsはNov 13, 2025に四半期決算を発表しました:
